Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Dermatology Reports
Published in: Current Dermatology Reports 4/2023

14-12-2023 | Telemedicine | REVIEW

Teledermatology Lessons During the COVID-19 Pandemic

Authors: Zachary Brown, Allison Dobry

Published in: Current Dermatology Reports | Issue 4/2023

Login to get access

Abstract

Purpose of review

The purpose of this review is to highlight the parallel changes in practice, regulatory, and reimbursement patterns for teledermatology before, during, and after the coronavirus disease 2019 (COVID-19) pandemic.

Recent findings

There was a sharp increase in teledermatology utilization by both patients and dermatologists during the COVID-19 pandemic. The rise in teledermatology use can be attributed to governmental changes in regulation that allowed greater flexibility in care delivery as well as a higher degree of access and payment parity for teledermatology as compared to in-person dermatology.

Summary

The confluence of a greater need for virtual care in conjunction with a more permissive regulatory environment and equitable pay structure was the impetus for teledermatology becoming a standard model of healthcare delivery in the USA. Whether teledermatology will continue to a viable model in the future years, however, will be dependent on whether these regulatory and payment structures can remain in place for the long term.
Literature
1.
•• Lee JJ, English JC. Teledermatology: a review and update. Am J Clin Dermatol. 2018;19(2):253–60. This is a comprehensive text on the history of teledermatology and general types ot teledermatology there are.
2.
3.
Gonçalves L, Cunha C. Telemedicine project in the Azores Islands. Arch Anat Cytol Pathol. 1995;43(4):285–7.PubMed
4.
Menn ER, Kvedar JC. Teledermatology in a changing health care environment. Telemed J Off J Am Telemed Assoc. 1995;1(4):303–8.
5.
6.
Murphy RL, Fitzpatrick TB, Haynes HA, Bird KT, Sheridan TB. Accuracy of dermatologic diagnosis by television. Arch Dermatol. 1972;105(6):833–5.CrossRefPubMed
7.
Tensen E, van der Heijden JP, Jaspers MWM, Witkamp L. Two decades of teledermatology: current status and integration in national healthcare systems. Curr Dermatol Rep. 2016;5:96–104.CrossRefPubMedPubMedCentral
8.
Xiang DH, He LD, Nambudiri VE, LaChance A. Trends in dermatology telehealth uptake in Medicare beneficiaries from 2010 to 2020: a retrospective cross-sectional analysis. J Am Acad Dermatol. 2023;88(5):1214–5.CrossRefPubMed
9.
10.
Gronbeck C, Grant-Kels JM, Lu J, Feng H. Increased utilization of teledermatology among Medicare part B beneficiaries during the COVID-19 pandemic. Clin Dermatol. 2022;40(6):760–3.CrossRefPubMedPubMedCentral
11.
Marinelli S, Basile G, Zaami S. Telemedicine, Telepsychiatry and COVID-19 pandemic: future prospects for global health. Healthc Basel Switz. 2022;10(10):2085.
12.
Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, et al. Hospital-level care at home for acutely ill adults: a randomized controlled trial. Ann Intern Med. 2020;172(2):77–85.CrossRefPubMed
13.
14.
Hoffman DA. Increasing access to care: telehealth during COVID-19. J Law Biosci. 2020;7(1):lsaa043.
15.
16.
17.
18.
19.
Kane S, Admani S. COVID-19 pandemic leading to the accelerated development of a virtual health model for isotretinoin. J Dermatol Nurses Assoc. 2021;13(1):54–7.CrossRefPubMed
20.
Pathoulas JT, Farah RS, Fiessinger L, Mansh M. An opportunity for improvement: iPLEDGE policy changes during the coronavirus pandemic. Dermatol Ther. 2020;33(6):e14411.CrossRefPubMedPubMedCentral
21.
22.
Ibrahim AE, Magdy M, Khalaf EM, Mostafa A, Arafa A. Teledermatology in the time of COVID-19. Int J Clin Pract. 2021;75(12): e15000.CrossRefPubMed
23.
SteelFisher GK, McMurtry CL, Caporello H, Lubell KM, Koonin LM, Neri AJ, et al. Video telemedicine experiences in COVID-19 were positive, but physicians and patients prefer in-person care for the future. Health Aff Proj Hope. 2023;42(4):575–84.CrossRef
24.
•• Lin SK, Deitermann AM, Miller CJ, Garg A, Ungar J, Nguyen HP. Evolving teledermatology policy and reimbursement landscape in the United States. JAAD Int. 2023;29(11):200–8. This is an important update on policy change and reimbursement patterns for teledermatology within the United States.
25.
•• Kennedy J, Arey S, Hopkins Z, Tejasvi T, Farah R, Secrest AM, et al. Dermatologist perceptions of teledermatology implementation and future use after COVID-19: demographics, barriers, and insights. JAMA Dermatol. 2021;157(5):595–7. This manuscript focuses on the impact of COVID-19 on popularity of teledermatology among dermatologists.
26.
Dobry A, Almanza J, Stavert R. Teledermatology: platforms. In: English III JC, editor. Teledermatology: a comprehensive overview [Internet]. Cham: Springer International Publishing; 2023 [cited 2023 Aug 14]. p. 1–8. (Updates in Clinical Dermatology). Available from: https://​doi.​org/​10.​1007/​978-3-031-27276-9_​1.
27.
Resneck JS, Abrouk M, Steuer M, Tam A, Yen A, Lee I, et al. Choice, transparency, coordination, and quality among direct-to-consumer telemedicine websites and apps treating skin disease. JAMA Dermatol. 2016;152(7):768–75.CrossRefPubMed
28.
Vidmar DA. The history of teledermatology in the Department of Defense. Dermatol Clin. 1999;17(1):113–24, ix.
29.
Rosenbaum BE, Campion CH, Cohen JM, Latkowski JA. The department of defense: pioneers of early teledermatology. Dermatol Online J. 2017;23(2):13030/qt84v5t8vd.
30.
Jallow M, Ewulu A, Ajilore P, Hussain AN, Geng X, Cardis MA. Analyzing disparities in access to teledermatology compared with dermatology clinic visits before, during, and after COVID-19 quarantine. Clin Dermatol [Internet]. 2023;41(1). Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​36336317/​.
31.
Resneck JS, Isenstein A, Kimball AB. Few Medicaid and uninsured patients are accessing dermatologists. J Am Acad Dermatol. 2006;55(6):1084–8.CrossRefPubMed
32.
Alghothani L, Jacks SK, Vander Horst A, Zirwas MJ. Disparities in access to dermatologic care according to insurance type. Arch Dermatol. 2012;148(8):956–7.CrossRefPubMed
33.
Uscher-Pines L, Malsberger R, Burgette L, Mulcahy A, Mehrotra A. Effect of teledermatology on access to dermatology care among Medicaid enrollees. JAMA Dermatol. 2016;152(8):905–12.CrossRefPubMed
34.
Bezalel S, Fabri P, Park HS. Implementation of store-and-forward teledermatology and its associated effect on patient access in a veterans affairs dermatology clinic. JAMA Dermatol. 2015;151(5):556–7.CrossRefPubMed
35.
Chansky PB, Simpson CL, Lipoff JB. Implementation of a dermatology teletriage system to improve access in an underserved clinic: a retrospective study. J Am Acad Dermatol. 2017;77(5):975–7.CrossRefPubMed
36.
Zakaria A, Maurer T, Su G, Amerson E. Impact of teledermatology on the accessibility and efficiency of dermatology care in an urban safety-net hospital: a pre-post analysis. J Am Acad Dermatol. 2019;81(6):1446–52.CrossRefPubMed
37.
Dobry A, Begaj T, Mengistu K, Sinha S, Droms R, Dunlap R, et al. Implementation and impact of a store-and-forward teledermatology platform in an urban academic safety-net health care system. Telemed J E-Health Off J Am Telemed Assoc. 2021;27(3):308–15.
38.
Miller J, Ioffreda P, Nugent S, Jones E. Demographic data associated with digital inequity reported in patient-to-provider teledermatology studies in the United States from 2011 to 2021: scoping review. JMIR Dermatol [Internet]. 2023;6. Available from: https://​pubmed.​ncbi.​nlm.​nih.​gov/​36938315/​.
39.
Buster KJ, Stevens EI, Elmets CA. Dermatologic health disparities. Dermatol Clin. 2012;30(1):53–9, viii.
40.
Mahmood F, Bendayan S, Ghazawi FM, Litvinov IV. Editorial: the emerging role of artificial intelligence in dermatology. Front Med. 2021;8:751649.CrossRef
41.
Pannu S, Nguyen BM, Yang FSC, Rosmarin D. Predictors of patient experience with teledermatology in setting of COVID-19 pandemic in a single medical center. Int J Dermatol. 2021;60(5):626–7.CrossRefPubMed
42.
Coustasse A, Sarkar R, Abodunde B, Metzger BJ, Slater CM. Use of teledermatology to improve dermatological access in rural areas. Telemed J E-Health Off J Am Telemed Assoc. 2019;25(11):1022–32.
43.
Becker AL, Witkowski A, Ludzik J. Inequities in geriatric access to teledermatology and smartphone dermoscopy. Dermatol Rep. 2023;15(2):9612.
44.
Eberly LA, Khatana SAM, Nathan AS, Snider C, Julien HM, Deleener ME, et al. Telemedicine outpatient cardiovascular care during the COVID-19 pandemic: bridging or opening the digital divide? Circulation. 2020;142(5):510–2.CrossRefPubMedPubMedCentral
45.
Hadeler E, Prose N, Floyd LP. Teledermatology: how it is impacting the underserved. Pediatr Dermatol. 2021;38(6):1597–600.CrossRefPubMed
46.
Hartford EA, Carlin K, Rutman LE, Lion KC. Changes in rates and modality of interpreter use for pediatric emergency department patients in the COVID-19 era. Jt Comm J Qual Patient Saf. 2022;48(3):139–46.PubMed
47.
Zakaria A, Miclau TA, Maurer T, Leslie KS, Amerson E. Cost minimization analysis of a teledermatology triage system in a managed care setting. JAMA Dermatol. 2021;157(1):52–8.CrossRefPubMed
48.
Datta SK, Warshaw EM, Edison KE, Kapur K, Thottapurathu L, Moritz TE, et al. Cost and utility analysis of a store-and-forward teledermatology referral system: a randomized clinical trial. JAMA Dermatol. 2015;151(12):1323–9.CrossRefPubMed
49.
Pak HS, Datta SK, Triplett CA, Lindquist JH, Grambow SC, Whited JD. Cost minimization analysis of a store-and-forward teledermatology consult system. Telemed J E-Health Off J Am Telemed Assoc. 2009;15(2):160–5.
50.
Paquette S, Lin JC. Outpatient telemedicine program in vascular surgery reduces patient travel time, cost, and environmental pollutant emissions. Ann Vasc Surg. 2019;59:167–72.CrossRefPubMed
51.
Bynum AB, Irwin CA, Cranford CO, Denny GS. The impact of telemedicine on patients’ cost savings: some preliminary findings. Telemed J E-Health Off J Am Telemed Assoc. 2003;9(4):361–7.CrossRef
52.
Morton CA, Downie F, Auld S, Smith B, van der Pol M, Baughan P, et al. Community photo-triage for skin cancer referrals: an aid to service delivery. Clin Exp Dermatol. 2011;36(3):248–54.CrossRefPubMed
53.
Hsiao JL, Oh DH. The impact of store-and-forward teledermatology on skin cancer diagnosis and treatment. J Am Acad Dermatol. 2008;59(2):260–7.CrossRefPubMed
Metadata
Title
Teledermatology Lessons During the COVID-19 Pandemic
Authors
Zachary Brown
Allison Dobry
Publication date
14-12-2023
Publisher
Springer US
Published in
Current Dermatology Reports / Issue 4/2023
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-023-00416-6

Other articles of this Issue 4/2023

Current Dermatology Reports 4/2023 Go to the issue

REVIEW

Incontinence-Associated Dermatitis: a Practical Guide for the Consulting Dermatologist

Correction

Correction: Oral Minoxidil Therapy in Hair Loss: Where Do We Stand?

REVIEW

Update on Cutaneous Small Vessel Vasculitis: Terminology, Morphology, Diagnostic Evaluation, and Management

REVIEW

Toward a Molecular Diagnosis: Looking Under the Skin at Allergic Contact Dermatitis

HOT TOPIC

Oral Minoxidil Therapy in Hair Loss: Where Do We Stand?

REVIEW

Inpatient Evaluation and Management of Generalized Pustular Dermatoses